XIKANG CLOUD (09686) released its interim results, reporting an adjusted net loss of 21.847 million yuan, a year-on-year decrease of 43.11%.
Xikang Cloud Hospital (09686) announced its interim results for the six months ending June 30, 2026. The group achieved revenue of 183 million yuan, an increase of 2.39% year-on-year; the loss attributable to the owners of the parent company was 27.431 million yuan, a decrease of 43.89% year-on-year; the adjusted net loss was 21.847 million yuan, a decrease of 43.11% year-on-year; loss per share was 0.03 yuan.
XIKANG CLOUD (09686) released its interim results for the six months ended June 30, 2026, reporting revenue of 183 million yuan, an increase of 2.39% year-on-year; the loss attributable to shareholders of the parent company was 27.431 million yuan, a decrease of 43.89% year-on-year; the adjusted net loss was 21.847 million yuan, down 43.11% year-on-year; and the loss per share was 0.03 yuan.
During the reporting period, the net loss decreased by 45.1% to 27.4 million yuan, attributed to the continued release of gross profit growth driven by the scale effect of the nursing business, enhanced operational efficiency through improved organizational effectiveness, optimized resource allocation, and deep AI technology empowerment, as well as improved performance and reduced losses of joint ventures.
Related Articles

MICOT PHARMA-B (02335): The Phase II clinical trial of MT200605 for acute ischemic stroke (AIS) has been completed in China.

CIRRUS (02507) announced its interim results, with a net profit of $88.123 million, an increase of 35.6% year-on-year.

ASIA TELE-NET (00679) announced its interim results, reporting a loss attributable to shareholders of HKD 19.41 million.
MICOT PHARMA-B (02335): The Phase II clinical trial of MT200605 for acute ischemic stroke (AIS) has been completed in China.

CIRRUS (02507) announced its interim results, with a net profit of $88.123 million, an increase of 35.6% year-on-year.

ASIA TELE-NET (00679) announced its interim results, reporting a loss attributable to shareholders of HKD 19.41 million.

RECOMMEND





